Kevin Pirruccio1, Matthew Sloan2, Neil P Sheth3. 1. Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA. 2. Department of Orthopaedic Surgery, University of Pennsylvania, 3737 Market Street, 6th Floor, Philadelphia, PA, 19104, USA. 3. Chief of Orthopaedic Surgery at Pennsylvania Hospital, Assistant Professor of Orthopaedic Surgery, Department of Orthopaedic Surgery University of Pennsylvania, 800 Spruce Street, 8th Floor Preston Building, Philadelphia, PA, 19107, USA.
Abstract
INTRODUCTION: The prevalence of obesity continues to rise in parallel with demand for total hip arthroplasty (THA). This study aims to report obesity trends in primary THA and its effects on procedure outcomes in the United States, stratifying based on Body Mass Index (BMI). METHODS: Primary THA procedures were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2008-2016). Patient demographic (including BMI), primary outcomes (death; serious morbidity), and secondary outcome variables were analyzed. Using BMI comparison groups (Obese: BMI > 30 [O]; Morbidly Obese: BMI > 40 [MO]) for case populations, univariate, propensity score-matched, and multivariate logistic regression analyses were performed. RESULTS: The prevalence of obesity increased among primary THA (2008: 546/1200 [45.5%], 2016: 16,078/34,137 [47.1%]) cases. Data on 135,013 primary THA cases were analyzed. Propensity score-matched analyses demonstrated that both serious morbidity (O: OR = 0.73, p < 0.001; MO: OR = 0.84, p = 0.001) and frequency of discharges home (O: OR = 0.90, p < 0.001; MO: OR = 0.71, p < 0.001) were significantly reduced. Instead, long operative times (O: OR = 1.30, p < 0.001; MO: OR = 1.53, p < 0.001), readmission (O: OR = 1.27, p < 0.001; MO: OR = 1.49, p < 0.001), and reoperation (O: OR = 1.44, p < 0.001, MO: OR = 1.96, p < 0.001) were all significantly increased in both obese and morbidly obese cases. Death (OR = 0.29; p = 0.016) was decreased in the MO cohort, while length of stay (OR = 1.19, p = 0.004) was increased in the MO cohort. CONCLUSION: Both obese and morbidly obese primary THA patient populations were associated with variably increased complication risks; morbidly obese patients had higher complication rates relative to obese patients. Orthopaedic surgeons should continue to consider obesity as a risk factor for THA complications. However, given similar functional outcomes and satisfaction levels as non-obese patients, denying patients THA surgery based on BMI alone may merit reconsideration.
INTRODUCTION: The prevalence of obesity continues to rise in parallel with demand for total hip arthroplasty (THA). This study aims to report obesity trends in primary THA and its effects on procedure outcomes in the United States, stratifying based on Body Mass Index (BMI). METHODS: Primary THA procedures were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2008-2016). Patient demographic (including BMI), primary outcomes (death; serious morbidity), and secondary outcome variables were analyzed. Using BMI comparison groups (Obese: BMI > 30 [O]; Morbidly Obese: BMI > 40 [MO]) for case populations, univariate, propensity score-matched, and multivariate logistic regression analyses were performed. RESULTS: The prevalence of obesity increased among primary THA (2008: 546/1200 [45.5%], 2016: 16,078/34,137 [47.1%]) cases. Data on 135,013 primary THA cases were analyzed. Propensity score-matched analyses demonstrated that both serious morbidity (O: OR = 0.73, p < 0.001; MO: OR = 0.84, p = 0.001) and frequency of discharges home (O: OR = 0.90, p < 0.001; MO: OR = 0.71, p < 0.001) were significantly reduced. Instead, long operative times (O: OR = 1.30, p < 0.001; MO: OR = 1.53, p < 0.001), readmission (O: OR = 1.27, p < 0.001; MO: OR = 1.49, p < 0.001), and reoperation (O: OR = 1.44, p < 0.001, MO: OR = 1.96, p < 0.001) were all significantly increased in both obese and morbidly obese cases. Death (OR = 0.29; p = 0.016) was decreased in the MO cohort, while length of stay (OR = 1.19, p = 0.004) was increased in the MO cohort. CONCLUSION: Both obese and morbidly obese primary THA patient populations were associated with variably increased complication risks; morbidly obese patients had higher complication rates relative to obese patients. Orthopaedic surgeons should continue to consider obesity as a risk factor for THA complications. However, given similar functional outcomes and satisfaction levels as non-obese patients, denying patients THA surgery based on BMI alone may merit reconsideration.
Entities:
Keywords:
Complications; NSQIP; Obesity; Outcomes; Propensity score-matching; Total hip arthroplasty
Authors: Thomas K Fehring; Susan M Odum; William L Griffin; J Bohannon Mason; Thomas H McCoy Journal: J Arthroplasty Date: 2007-07-26 Impact factor: 4.757
Authors: Fortune J Egbulefu; JaeWon Yang; John C Segreti; Scott M Sporer; Antonia F Chen; Matthew S Austin; Craig J Della Valle Journal: Arthroplast Today Date: 2022-08-27
Authors: Nishanth Muthusamy; Thomas Christensen; Vivek Singh; Chelsea Sue Sicat; Joshua C Rozell; Ran Schwarzkopf; Claudette M Lajam Journal: Arthroplasty Date: 2022-09-08